Splanchnic and systemic vasodilatation: The patient

Journal of Clinical Gastroenterology

Volumn 41, Issue SUPPL. 3, 2007, Pages

  Tsai, Ming Hung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Liver cirrhosis; Portal hypertension; Vasodilatation

Indexed keywords

ARTERIAL OXYGEN SATURATION; BRAIN CIRCULATION; CONFERENCE PAPER; CORRELATION ANALYSIS; DISEASE COURSE; ESOPHAGUS VARICES; HEMODYNAMICS; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HUMAN; KIDNEY CIRCULATION; LIVER CIRRHOSIS; MOLECULAR DYNAMICS; MULTIPLE ORGAN FAILURE; PATHOGENESIS; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; SYSTEMIC CIRCULATION; VARICOSIS; VASCULAR RESISTANCE; VASODILATATION;

ARTERIES; CARDIAC OUTPUT; CEREBROVASCULAR CIRCULATION; CORONARY CIRCULATION; HEPATORENAL SYNDROME; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; PULMONARY CIRCULATION; RENAL CIRCULATION; SPLANCHNIC CIRCULATION; VASODILATION;

EID: 35848949525     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181576d1a     Document Type: Conference Paper

References (82)

1. Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec cirrhosis. J Clin Invest. 1953;32:1025-1033.
2. Murray JG, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med. 1958;24:358-367.
3. Abelmann WH, Kowalski HJ, Mcneely WF. The hemodynamic response to exercise in patients with Laennec's cirrhosis. J Clin Invest. 1955;34:690-695.
4. Claypool JG. Hemodynamic studies in patients with Laennec's cirrhosis. Am J Med Sci. 1957;234:48-55.
5. Bayley TJ, Segel N, Bishop JM. The circulatory changes in patients with cirrhosis of liver at rest and during exercise. Clin Sci. 1964;26:227-235.
6. Cohn JN, Khatri IM, Groszmann RJ, et al. Hepatic blood flow in alcoholic liver disease measured by an indicator dilution technique. Am J Med. 1972;53:704-714.
7. Kontos HH, Shapiro W, Mauck HP, et al. General and regional circulatory alterations in cirrhosis of the liver. Am J Med. 1964;37:526-535.
8. Groszmann RJ, Abraldes JG. Portal hypertension: from bedside to bench. J Clin Gastroenterol. 2005;39:S125-S130.
9. Braillon A, Moreau R, Hadengue A, et al. Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol. J Hepatol. 1989;9:312-318.
10. Harada A, Nonami T, Kasai Y, et al. Systemic hemodynamics in non-cirrhotic portal hypertension-a clinical study of 19 patients. Japanese J Surg. 1988;18:620-625.
11. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology. 1994;20:1359-1363.
12. Llach J, Gines P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment ascites. Gastroenterology. 1988;94:482-487.
13. Del Guercio LRM, Commarawasmy RP, Feins NR, et al. Pulmonary arteriovenous admixture and the hyperdynamic cardiovascular state in surgery for portal hypertension. Surgery. 1964;56:57-74.
14. Waxman K, Shoemaker WC. Physiologic determinants of operative survival after portocaval shunt. Ann Surg. 1983;197:72-78.
15. Kotelanski B, Groszmann RJ, Cohn JN. Circulation times in the splanchnic and hepatic beds in alcoholic liver disease. Gastroenterology. 1972;63:102-111.
16. Williams R, Condon RE, Williams HS, et al. Splenic blood flow in cirrhosis and portal hypertension. Clin Sci. 1968;34:441-452.
17. Piscaglia F, Gaiani S, Gramantieri L, et al. Superior mesenteric artery impedance in chronic liver diseases: relationship with disease severity and portal circulation. Am J Gastroenterol. 1998;9310:1925-1930.
18. Groszmann RJ, Vorobioff J, Riley E. Splanchnic hemodynamics in portal hypertensive rats: measurement with γ-labeled microspheres. Am J Physiol. 1982;242:G156-G160.
19. Vorobioff J, Bredfeldt JE, Groszmann RJ. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology. 1984;87:1120-1126.
20. Groszmann RJ, Loureiro-Silva M, Tsai MH. The biology of portal hypertension. In: Arias IM, Jakoby WB, Schachter DA, et al, eds. The Liver-Biology and Pathobiology. 4th ed. New York: Lippincott Williams & Wilkins; 2001:679-697.
21. Whipple AO. The problem of portal hypertension in relation to hepatosplenopathies. Ann Surg. 1945;122:449-475.
22. Moreno AH, Burchell AR, Rousselot LM, et al. Portal blood flow in cirrhosis of the liver. J Clin Invest. 1967;46:436-445.
23. Britton RC. Influence of portal-systemic collateral patterns and distribution of varices on results of surgical treatment of bleeding esophageal varices. Surgery. 1963;53:567-578.
24. Butler H. The veins of esophagus. Thorax. 1951;6:267-296.
25. Bosch J, Groszmann RJ. Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis. Hepatology. 1984;4:424-429.
26. Bosch J, Mastai R, Kravetz D, et al. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with liver cirrhosis. J Hepatol. 1985;1:125-139.
27. Moller S, Bendtsen F, Christensen E, et al. Prognostic variables in patients with cirrhosis and esophageal varices without prior bleeding. J Hepatol. 1994;21:940-946.
28. Graham RM, Pettinger WA. Drug therapy-prazosin. New Eng J Med. 1979;300:232-236.
29. Pagani MS, Vatner SF, Braunwald E. Hemodynamic effects of intravenous nitroprusside in the conscious dog. Circulation. 1978;57:144-157.
30. Styles M, Coleman AJ, Leary WP. Some hemodynamic effects of sodium nitroprusside. Anesthesiology. 1973;38:173-176.
31. Schlant RC, Tsagaris TS, Robertson RJ. Studies on the acute cardiovascular effects of intravenous sodium nitroprusside. Am J Cardiol. 1962;9:51-59.
32. Guyton AC, Lindsey AW, Kaufmann B. Effect of mean circulatory filling pressure and other peripheral circulatory factors on cardiac output. Am J Physiol. 1955;180:463-468.
33. Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8:1151-1157.
34. Gines P, Martin PY, Niederberger M. Prognostic significance of renal dysfunction in cirrhosis. Kidney Int Suppl. 1997;61:S77-S82.
35. Lotterer E, Wengert A, Fleig W. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis. Hepatology. 1999;29:632.
36. Bernadich C, Bandi JC, Piera C, et al. Circulatory effects of graded diversion of portal blood flow to the systemic circulation in rats: role of nitric oxide. Hepatology. 1997;26:262-267.
37. Guyton AC, Hall JE. Cardiac Output, Venous Return, and Their Regulation. Textbook of Medical Physiology. 10th ed. New York: WB Saunders; 2000:210-222.
38. Sabbá C, Ferraioli G, Genecin P, et al. Evaluation of postprandial hyperemia in superior mesenteric artery and portal vein in healthy and cirrhotic humans: an operator-blind echo-Doppler study. Hepatology. 1991;13:714-718.
39. Zwiebel WJ, Mountford RA, Halliwell MJ, et al. Splanchnic blood flow in patients with cirrhosis and portal hypertension: investigation with duplex Doppler US. Radiology. 1995;194:807-812.
40. Albillos A, Rossi I, Cacho G, et al. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Physiol. 1995;268:G459-G464.
41. Rodriguez-Perez F, Isales CM, Groszmann RJ. Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis. Gastroenterology. 1993;105:863-867.
42. Luca A, García-Pagán JC, Feu F, et al. Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis. Hepatology. 1995;21:83-88.
43. Maroto A, Ginès P, Arroyo V, et al. Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction. Hepatology. 1993;17:788-793.
44. Fernandez-Seara J, Prieto J, Quiroga J, et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology. 1989;97:1304-1312.
45. Iwao T, Oho K, Sakai T, et al. Splanchnic and extrasplanchnic arterial hemodynamics in patients with cirrhosis. J Hepatol. 1997;27:817-823.
46. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology. 1996;24:451-459.
47. Wong F, Girgrah N, Graba J, et al. The cardiac response to exercise in cirrhosis. Gut. 2001;49:268-275.
48. Grose RD, Nolan J, Dillon JF, et al. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol. 1995;22:326-332.
49. Gould L, Shariff M, Zahir M, et al. Cardiac hemodynamics in alcoholic patients with chronic liver disease and a presystolic gallop. J Clin Invest. 1969;48:860-868.
50. Pozzi M, Carugo S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology. 1997;26:1131-1137.
51. Torregrosa M, Aguadé S, Dos L, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol. 2005;42:68-74.
52. Tuchschmidt J, Fried J, Astiz M, et al. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest. 1992;102:216-220.
53. Navasa M, Feu F, García-Pagán JC, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology. 1993;17:355-360.
54. Abrams GA, Jaffe CC, Hoffer PB, et al. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology. 1995;109:1283-1288.
55. Fallon MB. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome. J Clin Gastroenterol. 2005;39:S138-S142.
56. Schenk P, Schöniger-Hekele M, Fuhrmann V, et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology. 2003;125:1042-1052.
57. Caruso G, Catalano D. Esophageal varices and hepato-pulmonary syndrome in liver cirrhosis. J Hepatol. 1991;12:262-263.
58. Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest. 1993;104:515-521.
59. Rodriguez-Roisin R. The hepatopulmonary syndrome: new name, old complexities. Thorax. 1992;47:897-902.
60. Katsuta Y, Honma H, Zhang XJ, et al. Pulmonary blood transit time and impaired arterial oxygenation in patients with chronic liver disease. J Gastroenterol. 2005;40:57-63.
61. Genovesi MG, Tierney DF, Taplin GV, et al. An intravenous radionuclide method to evaluate hypoxemia caused by abnormal alveolar vessels. Limitation of conventional techniques. Am Rev Respir Dis. 1976;114:59-65.
62. Edell ES, Cortese DA, Krowka MJ, et al. Severe hypoxemia and liver disease. Am Rev Respir Dis. 1989;140:1631-1635.
63. Castaing Y, Manier G. Hemodynamic disturbances and VA/Q matching in hypoxemic cirrhotic patients. Chest. 1989;96:1064-1069.
64. Arguedas MR, Drake BB, Kapoor A, et al. Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome. Gastroenterology. 2005;128:328-333.
65. Rolla G, Brussino L, Colagrande P, et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology. 1997;26:842-847.
66. Gómez FP, Barberà JA, Roca J, et al. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology. 2006;43:1084-1091.
67. Dworkin LD, Brenner BM. The renal circulation. In: Brenner BM, ed. The Kidney. 7th edn. Philadelphia: Saunders; 2004:309-352.
68. Epstein M, Schneider N, Befeler B. Relationship of systemic and intrarenal hemodynamics in cirrhosis. J Lab Clin Med. 1977;89:1175-1187.
69. Kew MC, Brunt PW, Varma RR, et al. Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet. 1971;2:504-510.
70. Gines P, Fernandez-Esparrach G, Arroyo V, et al. Pathogenesis of ascites in cirrhosis. Semin Liver Dis. 1997;17:175-189.
71. Bataller R, Gines P, Guevara M, et al. Hepatorenal syndrome. Semin Liver Dis. 1997;17:233-247.
72. Sieber C, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology. 1992;103:235-239.
73. Ruiz-del-Arbol L, Monescillo A, Arocena C, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology. 2005;42:439-447.
74. Ruiz-del-Arbol L, Urman J, Fernández J, et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 2003;38:1210-1218.
75. Guevara M, Ginès P, Fernández-Esparrach G, et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology. 1998;27:35-41.
76. Ortega R, Ginès P, Uriz J, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002;36:941-948.
77. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 1990;2:161-192.
78. Paulson OB, Strandgaard S. Hypertensive disease and cerebral circulation. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. Vol. 1. New York: Raven Press; 1995:445-464.
79. Larsen FS, Ejlersen E, Hansen BA, et al. Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure. J Hepatol. 1995;23:212-217.
80. Blei AT. Monitoring cerebral blood flow: a useful clinical tool in acute liver failure? Liver Transpl. 2005;11:1320-1322.
81. Lagi A, La Villa G, Barletta G, et al. Cerebral autoregulation in patients with cirrhosis and ascites. A transcranial Doppler study. J Hepatol. 1997;27:114-120.
82. Guevara M, Bru C, Ginès P, et al. Increased cerebrovascular resistance in cirrhotic patients with ascites. Hepatology. 1998;28:39-44.